Tweetovi

Blokirali ste korisnika/cu @Invicro

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Invicro

  1. 3. velj

    Join us on February 11th as Jacob Hesterman, Ph.D. and Howard Dobson, Ph.D. discuss translational aspects of intrathecal drug administration. Grab your spot here:

    Poništi
  2. 29. sij

    We are pleased to share this featured Nature Communications publication co-authored by our industry-leading neuro scientists. This study investigates (SV2A) levels in schizophrenia using novel PET imaging techniques. Read the full article here:

    Poništi
  3. 28. sij

    Learn how novel therapies in CNS drug development are dramatically reducing costs and helping to deliver effective new medications. Download the whitepaper here:

    Poništi
  4. 27. sij

    Join us on February 11th as Jacob Hesterman, Ph.D. and Howard Dobson, Ph.D. discuss translational aspects of intrathecal drug administration. Grab your spot here:

    Poništi
  5. 21. sij

    Join us in NYC on February 26 at the IO360 conference. Our CEO, Matt Silva Ph.D., will be sharing the latest insight in IO imaging.

    Poništi
  6. 16. sij

    Join us on February 11th as Jacob Hesterman, Ph.D. and Howard Dobson, Ph.D. discuss translational aspects of intrathecal drug administration. Grab your spot here:

    Poništi
  7. 15. sij

    Join us in NYC on February 26 at the IO360 conference. Our CEO, Matt Silva Ph.D., will be sharing the latest insight in IO imaging.

    Poništi
  8. 14. sij

    We are pleased to announce our strategic partnership with . Together, we will offer digital diagnostic and biomarker solutions to pharma sponsors around the world. Read the full release here:

    Poništi
  9. 8. sij

    We are honored to co-publish this article with in the AAPS journal supporting supporting clinical production of a CD8-targeting 89Zr-labeled antibody as a non-invasive imaging biomarker for cancer immunotherapy. Read the full article here:

    Poništi
  10. 8. sij

    Learn more about the advancements and challenges we face with imaging approaches in the immuno-oncology space here:

    Poništi
  11. 7. sij

    Missed our last webinar on imaging biomarkers in metastatic prostate cancer? Watch it here:

    Poništi
  12. 6. sij

    Heading to the Human Amyloid Imaging Conference in Miami on January 15? One of our leading scientists, Dr. Roger Gunn will be sharing how our novel TauIQ analytics platform can support your AD studies.

    Poništi
  13. 2. sij

    Did you know? Invicro offers monthly webinars bringing together global thought leaders and scientific experts. View our series here to download:

    Poništi
  14. 24. pro 2019.

    We are grateful for your support in 2019 and look forward to focusing on new paths in 2020. Wishing you a healthy holiday and a happy new year!

    Poništi
  15. 23. pro 2019.

    We are pleased to announce the new appointment of Dr. Matthew Silva as Chief Executive Officer of Invicro. Former CEO, Jack Hoppin, will move on to be the President of Konica Minolta Precision Medicine (KMPM). Read the full release here:

    Poništi
  16. 12. pro 2019.

    We are excited to announce that we have joined ’s INTIENT network. This platform will allow researchers access to our novel software solutions and provide them insights from complex data at each drug phase.

    Poništi
  17. 11. pro 2019.

    We are excited to be at the Gene Therapy for Neurological Disorders Summit in Boston today and tomorrow. There have been many great discussions focused on the current challenges and future direction of gene therapies for CNS disorders.

    Poništi
  18. 3. lis 2019.

    Join us on October 10th as Patrick McConville, Ph.D. and our guest speaker Nina Timberlake,Ph.D. from Poseida Therapeutics, Inc. discuss state of the art applications that utilize luciferase reporters and bioluminescent imaging. Register here:

    Poništi
  19. 2. lis 2019.

    Heading to EANM next week? Stop by Booth #12 to learn how we can help you accelerate your drug discovery and development projects across all therapeutic areas. Schedule a meeting with us here:

    Poništi
  20. 30. ruj 2019.

    Join us on October 10th as Patrick McConville, Ph.D. and our guest speaker Nina Timberlake,Ph.D. from Poseida Therapeutics, Inc. discuss state of the art applications that utilize luciferase reporters and bioluminescent imaging. Register here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·